Our Team

The SoundSelf Team consists of industry experts in immersive technology, healthcare, and psychedelic medicine.


Robin Arnott

  • Former CEO of Andromeda Entertainment

  • Lead Developer of SoundSelf

  • Author of The Technodelic Manifesto

Robin’s LinkedIn

Chief Executive Officer

Sandeep Prakash, PhD

  • Psychedelic Researcher trained at California Institute of Integral Studies

  • Expert in leading psychedelic and DTx research

  • Over a decade of experience in transformative experience design

Sandeep’s LinkedIn

Chief Scientific Officer

Lyle Maxson

  • Rolling Stones Culture Council member

  • Visionary leader in the “Benevolent Technology” movement.

Lyle’s LinkedIn

Board Member

Advisory Board

Proven leaders in the mental health digital therapeutics space.


  • Founder of Akili Interactive and Neuroscape. 

  • Chief Scientist at Jazz Ventures.

  • Creator of EndeavorRX, the first videogame DTx to receive FDA Clearance.

  • UCSF Dolby Distinguished Professor of Neurology, Physiology and Psychiatry.

Dr. Adam Gazzaley, MD, Ph.D.

  • Executive Director of the Transformative Technology Lab

  • CEO of the Willow Group

  • Widely regarded as the maverick behind the Transformative Tech movement

Nichol Bradford

  • Clinical Psychologist with industry-leading expertise in 

  • Virtual Reality clinical trials

  • Chief architect of Applied VR's pioneering

  • FDA De Novo submission

  • Director of Research at Found

Dr. Laura Garcia, Ph.D.

  • CEO and founder of Being True to You (17+ Years)

  • Leader in the field of training coaches in psychedelic preparation and integration process.

  • Experienced business leadership in the wellness sector, and expert at scaling sustainable mental health organizations.

Deanna Adamson

  • Assistant Professor at the University of Wisconsin School of Medicine and Public Health & Transdisciplinary Center for Research in Psychoactive Substances

  • Principal Investigator and therapist for MAPS phase 3 multi-site trial

  • Extensively published in clinical efficacy & therapeutic mechanisms of psychedelic & other psychoactive compounds for addiction, trauma, chronic pain, & depression

Dr. Christopher Nicholas, Ph.D.

  • CEO at Microdose Psychedelic Insights

  • Market access expert for psychedelic industry

  • Super-connector of the psychedelic renaissance

Patrick Moher